AGM
EFTRW

Alpine Global Management’s eFFECTOR Therapeutics, Inc. Warrant EFTRW Stock Holding History

Alpine Global Management’s Portfolio EFTRW Stock Details EFTRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-40,450
Closed -$65K – 827
2021
Q3 		$65K Buy
+40,450
New +$49.1K 0.01% 265

Other funds holding EFTRW

AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
ICMH
Integrity Capital Management (HK) Central, Hong Kong $64K AUM
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return

Alpine Global Management's EFTRW Position: Q4 2021 in Review

Alpine Global Management sold out of eFFECTOR Therapeutics, Inc. Warrant (EFTRW) in Q4 2021, closing a stake of 40,450 shares — an estimated $65K sold.

Alpine Global Management first reported a position in EFTRW in Q3 2021 and held it in 1 quarter. The position peaked at $65K in Q3 2021. 17 funds tracked by Wall St. Rank hold EFTRW as of Q4 2021.

  • Alpine Global Management reported no remaining eFFECTOR Therapeutics, Inc. Warrant position as of Q4 2021 after selling out during the quarter.
  • Alpine Global Management sold 40,450 eFFECTOR Therapeutics, Inc. Warrant shares in Q4 2021, an estimated $65K.
  • Alpine Global Management first reported a position in eFFECTOR Therapeutics, Inc. Warrant in Q3 2021 and held it in 1 quarter.
  • Alpine Global Management's eFFECTOR Therapeutics, Inc. Warrant position peaked at $65K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Warrant as of Q4 2021.

Based on Alpine Global Management's 13F filing for Q4 2021, filed 14 Feb 2022.